BRITTNI CLARK: Open Payments
NPI 1669114070 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 11 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $889 · 2025 $1,261
Food & beverage: $1,261
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $500 |
| Astellas Pharma US Inc | 2 | $248 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Sage Therapeutics, LLC | 1 | $120 |
| Viatris Specialty LLC | 1 | $19 |
Products named: QULIPTA, Veozah, Auvelity, IBSRELA, VRAYLAR, Wegovy, UBRELVY, YUPELRI.
Industry payments across LA — which companies pay providers there.
